---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-008825"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:53:25.268178+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA Pharma transfers listing to Nasdaq Capital Market to regain bid price compliance

## Summary
- Received Nasdaq approval to transfer common stock listing from Global Select Market to Capital Market effective Feb 1, 2024.
- Granted a second 180-day compliance period until July 29, 2024 to meet $1.00 minimum bid price requirement.
- Company must close at $1.00 per share for 10 consecutive business days to regain compliance.
- If compliance not achieved by July 29, 2024, Nasdaq may delist the stock; Company may appeal.
- Company intends to cure deficiency via a reverse stock split if necessary.

## SEC filing metadata
- accession: 0001104659-24-008825
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/0001104659-24-008825-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/tm244750d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-008825
- JSON: https://secwatch.observer/filing/0001104659-24-008825.json
- Plain text: https://secwatch.observer/filing/0001104659-24-008825.txt

## Key facts
- Listing & Compliance Notices
  HOOKIPA Pharma Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: from The Nasdaq Global Select Market tier to The Nasdaq Capital Market tier, as well as the Company’s request for a second 180-calendar day period, or until July 29, 2024 (the “Second Compliance Period”), to regain compliance with the $1.00 bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2). To regain compliance with such minimum price requirement, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. The transfer of the listing of the Company’s Common Stock from The Nasdaq Global Select Market to The Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/0001104659-24-008825-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.